Long-term Overall Survival after External Beam Radiotherapy for Localised Prostate Cancer

Autor: Jahreiβ, M.-C. ^∗, Incrocci, L. ^∗, Dirkx, M. ^∗, de Vries, K.C. ^∗, Aben, K.K.H. ^{†, ‡}, Bangma, C. ^§, Heemsbergen, W.D. ^∗

Publikováno v: In Clinical Oncology December 2023 35(12):e689-e698

Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?

Autor: Nuijens, S.T., Hoogstraten, L.M.C. van, Meijer, R.P., Kiemeney, L.A.L.M., Aben, K.K.H., Witjes, J.A.

Publikováno v: European Urology Open Science, 51, 47-54
European Urology Open Science, 51, pp. 47-54

Contains fulltext : 292901.pdf (Publisher’s version ) (Open Access) BACKGROUND: Minimum volume standards (MVS) for hospitals and/or surgeons remain a subject of debate. Opponents of MVS emphasize the possible negative effects of centralization, suc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d9ae0ed2b88f0af918b28db57891d0
https://doi.org/10.1016/j.euros.2023.02.015

Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine

Autor: Haar-Holleman, Amy de, Hoogstraten, L.M.C. van, Hulshof, Maarten C.C.M., Tascilar, M., Bruck, Katharin, Meijer, Richard P., Witjes, J.A., Kiemeney, L.A., Aben, K.K.H.

Publikováno v: Radiotherapy and Oncology, 183
Radiotherapy and oncology, 183:109584. Elsevier Ireland Ltd

Background and purpose: Oral capecitabine and intravenous 5-fluorouracil (5-FU) are both used as a radiosensitizer in chemoradiotherapy (CRT). A capecitabine-based regimen is more convenient for both patients and healthcare professionals. Since large

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1914873372bceb215a48d2d0d8a8a76
http://www.scopus.com/inward/record.url?scp=85152058185&partnerID=8YFLogxK

Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy

Autor: Hoogstraten, L.M.C. van, Gennep, E.J. van, Kiemeney, L.A.L.M., Witjes, J.A., Voskuilen, C.S., Deelen, M., Mertens, L.S., Meijer, R.P., Boormans, J.L., Robbrecht, D.G.J., Beerepoot, L.V., Verhoeven, R.H.A., Ripping, T.M., Rhijn, B.W.G. van, Aben, K.K.H., Hermans, T.J.N., BlaZIB Study Grp

Publikováno v: World Journal of Urology, 40, 1, pp. 111-118
World Journal of Urology, 40, 111-118. SPRINGER
World journal of urology, 40(1), 111-118. Springer Verlag
World Journal of Urology, 40(1), 111-118. Springer, Cham
BlaZIB Study Group 2022, ' Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy : a nationwide study of 5417 patients ', World Journal of Urology, vol. 40, no. 1, pp. 111-118 . https://doi.org/10.1007/s00345-021-03839-7
World Journal of Urology, 40, 111-118
World Journal of Urology, 40(1), 111-118. Springer Verlag
World Journal of Urology, 40(1), 111-118. Springer-Verlag

Purpose Little is known about the prevalence of occult lymph node metastases (LNM) in muscle-invasive bladder cancer (MIBC) patients with pathological downstaging of the primary tumor. We aimed to estimate the prevalence of occult LNM in patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41cf9f621762eb27131bc39e18a6c6bd
http://www.scopus.com/inward/record.url?scp=85124850919&partnerID=8YFLogxK

Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis

Autor: Fu, Z., Brooks, M.M., Irvin, S., Jordan, S., Aben, K.K.H., Anton-Culver, H., Bandera, E.V., Beckmann, M.W., Berchuck, A., Brooks-Wilson, A., Chang-Claude, J., Cook, L.S., Cramer, D.W, Cushing-Haugen, K.L., Doherty, J.A., Ekici, A.B., Fasching, P.A., Fortner, R.T., Gayther, S.A., Gentry-Maharaj, A., Giles, G.G., Goode, E.L., Goodman, M.T., Harris, H.R., Hein, A., Kaaks, R., Kiemeney, L.A., Köbel, M., Kotsopoulos, J., Le, N.D., Lee, A.W.C., Matsuo, K., McGuire, V., McLaughlin, J.R., Menon, U., Milne, R.L., Moysich, K.B., Pearce, C.L., Pike, M.C., Qin, B., Ramus, S.J., Riggan, M.J., Rothstein, J.H., Schildkraut, J.M., Sieh, W., Sutphen, R., Terry, K.L., Thompson, P.J., Titus, L., Altena, A.M. van, White, E., Whittemore, A.S., Wu, A.H., Zheng, W., Ziogas, Argyrios, Taylor, S.E., Tang, L., Songer, T., Wentzensen, N., Webb, P.M., Risch, H.A., Modugno, F.

Publikováno v: Journal of the National Cancer Institute, 115, 5, pp. 539-551
Journal of the National Cancer Institute, 115, 539-551

Background The role of ovulation in epithelial ovarian cancer (EOC) is supported by the consistent protective effects of parity and oral contraceptive use. Whether these factors protect through anovulation alone remains unclear. We explored the assoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c4b7f2bffa032cd36c2285ca35feae1
https://repository.ubn.ru.nl/handle/2066/292720